Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 7.


Stainthorpe, Angela, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Houten, Rachel ORCID: 0000-0002-4315-7732, Chaplin, Marty, Boland, Angela, Beale, Sophie, Dundar, Yenal ORCID: 0000-0002-9847-1622, McEntee, Joanne and Syndikus, Isabel
(2020) Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics - open.


Fleeman, Nigel ORCID: 0000-0002-4637-9779, Stainthorpe, Angela, Houten, Rachel, Chaplin, Marty ORCID: 0000-0002-7097-8704, Boland, Angela, Beale, Sophie, Dundar, Yenal, Kotas, Eleanor, McEntee, Joanne and Isabel, Syndikus
(2018) Brentuximab vedotin for treating relapsed or refractory CD30-positive cutaneous T-cell lymphoma (17/56/12). [Report]


Fleeman, Nigel ORCID: 0000-0002-4637-9779, Mahon, James, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Duarte, Rui, Boland, Angela, Kotas, Eleanor, Dundar, Yenal ORCID: 0000-0002-9847-1622, McEntee, Joanne and Ahmad, Sajjad
(2019) Cenegermin for Treating Neurotrophic Keratitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics - open, 3 (4). 453 - 461.


Lambe, Tosin ORCID: 0000-0002-6229-2454, Duarte, Rui, Mahon, James, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Boland, Angela, Beale, Sophie ORCID: 0000-0003-0164-103X, Kotas, Eleanor, McEntee, Joanne and Pomeroy, Ian
(2019) Cladribine Tablets for the First-Line Treatment of Relapsing-Remitting Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS, 37 (3). 345 - 357.


Houten, Rachel ORCID: 0000-0002-4315-7732, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Mahon, James, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Beale, Sophie, Boland, Angela, Lambe, Tosin, Dundar, Yenal ORCID: 0000-0002-9847-1622, Kotas, Eleanor and McEntee, Joanne
(2020) Encorafenib with Binimetinib for the Treatment of Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics - open.


Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Duarte, Rui, Richardson, Marty ORCID: 0000-0002-7097-8704, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Boland, Angela, Kotas, Eleanor, McEntee, Joanne and Thorp, Nicky
(2019) Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics - open, 3 (3). 293 - 302.


Fleeman, Nigel ORCID: 0000-0002-4637-9779, Abdulla, Ahmed, Bagust, Adrian ORCID: 0000-0002-2142-5767, Beale, Sophie ORCID: 0000-0003-0164-103X, Richardson, Marty, Stainthorpe, Angela ORCID: 0000-0002-2531-9371, Boland, Angela, Kotas, Eleanor, McEntee, Joanne and Palmer, Daniel ORCID: 0000-0002-7147-5703
(2018) Pegylated Liposomal Irinotecan Hydrochloride Trihydrate for Treating Pancreatic Cancer After Gemcitabine: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS, 36 (3). 289 - 299.

This list was generated on Thu Nov 26 11:52:41 2020 GMT.